Guidelines International Network | Guidelines International Network (GIN)

Systemic therapy for advanced or recurrent endometrial cancer, and advanced or recurrent uterine papillary serous carcinoma

MeSH Terms: Endometrial Neoplasms (C04.588.945.418.948.585); Uterine Neoplasms (C04.588.945.418.948); Drug Therapy (E02.319); Drug Therapy; Combination (E02.319.310); Antineoplastic Agents (D27.505.954.248)
Guideline Contact: Cindy Walker-Dilks ([email protected])
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2017

Guideline Contact: Judy Brown; [email protected]
Date for Review: In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
Publication Date: 09/08/2022
Publication Scope: Guidelines; treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Publication Year: 2022

MeSH Terms: Neoplasms (C04); Breast Neoplasms (C04.588.180); Pharmacologic Actions (D27.505)
Guideline Contact: [email protected]
Publication Date: 25-Jun-18
Publication Scope: prognosis; treatment
Countries of Application: United States
Guideline Publication Status: Under Review
Languages: English
Authors: ASCO (US)
Publication Year: 2018

MeSH Terms: Ovarian Neoplasms (C04.588.322.455); Neoplasm Recurrence; Local (C04.697.655); Neoplasm Metastasis (C04.697.650)
Guideline Contact: Cindy Walker-Dilks ([email protected])
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2017

MeSH Terms: Drug Therapy; Combination (E02.319.310); Meta-Analysis as Topic (E05.581.500.501); Drug Therapy (E02.319)
Guideline Contact: Cindy Walker-Dilks ([email protected])
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2014

MeSH Terms: Consensus Development Conference (V03.300); Consensus (F01.829.316.068); Myelodysplastic Syndromes (C15.378.190.625)
Guideline Contact: Cindy Walker-Dilks ([email protected])
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2018

MeSH Terms: Neuroendocrine Carcinoma, Gastroenteropancreatic neuroendocrine tumor, Phase 3 Clinical Trial, Phase 4 Clinical Trial, Randomized Controlled Trial, Guideline, Systematic Review, Quality Assessment, Adult, Octreotide, 177Lu-Dotatate, 90y-Dotatate
Guideline Contact: Roxanne Cosby; [email protected]
Keywords: Guideline, Midgut Neuroendocrine Tumours, Pancreatic Neuroendocrine Tumours, Systemic Therapy, Systematic Review
Date for Review: The Program in Evidence-based Care (PEBC), Ontario Health (CCO) has an annual review process for each guideline. Guidelines are reviewed every fall, one year after they are completed
Publication Date: March 2024
Date of Last Evidence Search: October 30, 2023
Methods Applied: Evidence-based; Systematic review-based; External review; Evidence quality assessment; Patient/survivor/caregiver participation
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: PEBC (Program in evidenced-based care)
Publication Year: 2024

MeSH Terms: Drug Therapy (E02.319); Antineoplastic Agents (D27.505.954.248); Drug Therapy; Combination (E02.319.310); Prostatic Neoplasms (C04.588.945.440.770)
Guideline Contact: Cindy Walker-Dilks ([email protected])
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2005